Valeant Adds Energy To Its Aesthetics Offerings With Solta Medical

Valeant Pharmaceuticals says it will buy energy-based aesthetics device firm Solta Medical for about $250 million, to expand the breadth of its offerings to dermatologists and plastic surgeons.